| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lochner Daniel | Chief Financial Officer | C/O TECTONIC THERAPEUTIC, INC., 490 ARSENAL WAY, SUITE 210, WATERTOWN | /s/ Daniel Lochner | 29 Sep 2025 | 0001791187 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECX | Common Stock | Award | $0 | +5,430 | +24% | $0.000000 | 28,121 | 25 Sep 2025 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TECX | Employee Stock Option (Right to Buy) | Award | $0 | +9,860 | $0.000000 | 9,860 | 25 Sep 2025 | Common Stock | 9,860 | $14.71 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of September 25, 2026, September 25, 2027 and September 25, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |
| F2 | Please note that the total number of securities beneficially owned following the reported transaction has been corrected to reflect the correct amount. The amount reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 7, 2025 should have reflected that the total number of securities beneficially owned following the reported transaction was 22,691 shares instead of 4,617 shares. |
| F3 | The shares subject to the option vest in 48 equal monthly installments beginning on October 25, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |